|
FY2021
12 months to Dec 31, 2021
|
FY2020
4 months to Dec 31, 2020
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Change in fair value of warrant liabilities | ||
| Loss on initial issuance of Private Placement Warrants | ||
| Interest earned on marketable securities held in Trust Account | ||
| Transaction costs associated with the Initial Public Offering | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Accrued expenses | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment of cash into Trust Account | ||
| Net cash used in investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from sale of Units, net of underwriting discount paid | ||
| Proceeds from sale of Private Placements Warrants | ||
| Proceeds from promissory note - related party | ||
| Repayment of promissory note – related party | ||
| Payment of offering costs | ||
| Net cash provided by financing activities | ||
| Cash – Beginning | ||
| Cash – Ending | ||
| Net Change in Cash | ||
| Cash – Beginning of period | ||
| Cash – End of period | ||
| Non-Cash investing and financing activities: | ||
| Deferred offering costs included in accrued offering costs | ||
| Deferred offering costs paid by Sponsor in exchange for the issuance of Class B common stock | ||
| Offering costs included in accrued offering costs | ||
| Offering costs paid by Sponsor in exchange for issuance of founder shares | ||
| Remeasurement adjustment on redeemable common stock | ||
| Deferred underwriting fee payable | ||
| Initial classification of warrant liability |
Loading...
